Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M66.2Revenue $M0Net Margin (%)0Z-Score54.8
Enterprise Value $M66.1EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %0Quick Ratio0.1Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-21.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-22.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M10.4ROI % (ttm)-11.4Gross Margin Increase y-yN

Gurus Latest Trades with IMCL

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

IMCL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


IMCL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ICAHN CARL CDirector, 10% Owner 2008-11-21Sell11,669,544$70-96.43 view
CROWLEY RichardSVP, Biopharmaceutical Ops 2008-11-03Sell11,957$68.72-96.36 view
CROWLEY RichardSVP, Biopharmaceutical Ops 2008-09-02Sell11,957$64.4-96.12 view
CROWLEY RichardSVP, Biopharmaceutical Ops 2007-11-19Sell26,957$64.16-96.1 view
BAILEY MICHAEL PSVP, Commercial Ops 2007-11-19Sell14,750$64.16-96.1 view
CROWLEY RichardSVP, Biopharmaceutical Ops 2007-11-19Sell9,150$42.65-94.14 view
Johnson John HCEO 2007-09-07Buy13,609$36.74-93.2 view
BAILEY MICHAEL PSVP, Commercial Ops 2007-07-12Sell1,250$34.2-92.69 view
RAMANATHAN ERIKSenior Vice President, Legal 2006-10-13Sell9,996$30.9-91.91 view
RAMANATHAN ERIKSenior Vice President, Legal 2006-10-10Sell5,004$30.92-91.91 view

Press Releases about IMCL :

    Quarterly/Annual Reports about IMCL:

    News about IMCL:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    IMMUNOCLIN CORP Financials Sep 20 2014
    ImmunoClin Corporation (IMCL) Announces the Appointment of Infectious Disease Expert, Dr. Heinz... Aug 05 2014
    IMMUNOCLIN CORP Files SEC form 8-K, Other Events Aug 01 2014
    IMMUNOCLIN CORP Financials Jul 31 2014
    ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC Jul 29 2014
    IMMUNOCLIN CORP Files SEC form 10-Q, Quarterly Report Jul 24 2014
    IMMUNOCLIN CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial... Jul 08 2014
    ImmunoClin Corporation (IMCL) Recruits Prof. Jean Mariani to the Company's Scientific Advisory Board Jun 05 2014
    ImmunoClin Corporation (IMCL) Appoints Prof. Antony Bayer to the Company's Scientific Advisory Board May 27 2014
    ImmunoClin Corporation (IMCL) Announces the Appointment of Computing Systems Specialist and... May 22 2014
    ImmunoClin Corporation (IMCL) Proudly Announces the Appointment of Molecular Biologist and... Apr 30 2014
    IMMUNOCLIN CORP Files SEC form 8-K, Financial Statements and Exhibits Mar 04 2014
    IMMUNOCLIN CORP Files SEC form 8-K/A, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Feb 27 2014
    IMMUNOCLIN CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to... Feb 06 2014
    PHARMA INVESTING NEWS, INC. Financials Jan 25 2014
    PHARMA INVESTING NEWS, INC. Files SEC form 10-Q, Quarterly Report Jan 21 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK